Nicoletti GSG, Fadda G, Boros S, Nicolosi D, Marchese A, Spanu T, Pantosti A, Monaco M, Rezza G, Casosne A, Garaci E: Bacterial Isolates from Severe Infections and Their Antibiotic Susceptibility Patterns in Italy: a Nationwide Study in the Hospital Setting. Journal of Chemotherapy. 2006, 18: 589-602.
Article
CAS
PubMed
Google Scholar
Wilson SJCK, Zieger M, Gabehart K, Goodman J, Volk H, Sood R: Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. American Journal of Infection Control. 2004, 32 (6): 342-344. 10.1016/j.ajic.2004.02.008
Article
PubMed
Google Scholar
Giordano A, Varesi P, Bertini A, Villa L, Dionisi AM, Venditti M, Carfagna P, Luzzi I, Mancini C, Carattoli A: Outbreak of Acinetobacter baumannii Producing the Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Rome, Italy. Microbial Drug Resistance. 2007, 13 (1): 37-43. 10.1089/mdr.2006.9995
Article
CAS
PubMed
Google Scholar
Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P, Carattoli A: Multicopy blaOXA-58 Gene as a Source of High-Level Resistance to Carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007, 51 (7): 2324-2328. 10.1128/AAC.01502-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Thean Yen Tan M, Karen Poh, Siew Yong Ng: Molecular Typing of Imipenem-Resistant Acinetobacter baumannii-calcoaceticus Complex in a Singapore Hospital Where Carbapenem Resistance Is Endemic. Infection Control and Hospital Epidemiology. 2007, 28: 941-944. 10.1086/518964.
Article
PubMed
Google Scholar
Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J: Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii. J Clin Microbiol. 2007, 45 (2): 453-460. 10.1128/JCM.01971-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA: The Global Challenge of Multidrug Resistant (MDR) Acinetobacter baumannii. Antimicrob Agents Chemother. 2007, AAC.01464-01406.
Google Scholar
Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L: Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006, 50 (9): 2946-2950. 10.1128/AAC.00103-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Urban C, Mariano N, Rahal JJ, Tay E, Ponio C, Koprivnjak T, Weiss J: Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI21 and Cecropin P1. Antimicrob Agents Chemother. 2001, 45 (3): 994-995. 10.1128/AAC.45.3.994-995.2001
Article
PubMed Central
CAS
PubMed
Google Scholar
Li J, Nation RL, Turnidge , John D, Milne , Robert W, Coulthard , Kingsley , Rayner , Craig R, Patterson , David L: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet Infectious diseases. 2006, 6 (9): 589-601. 10.1016/S1473-3099(06)70580-1
Article
CAS
PubMed
Google Scholar
Livermore DM: Tigecycline: what is it and where should be used. Journal of Antimicrobial Chemotherapy. 2005, 56: 611-614. 10.1093/jac/dki291
Article
CAS
PubMed
Google Scholar
Testsurveillance.com. 2007,http://www.testsurveillance.com
Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA: In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007, 51 (5): 1621-1626. 10.1128/AAC.01099-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ: In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007, 60 (2): 317-322. 10.1093/jac/dkm136
Article
CAS
PubMed
Google Scholar
Institute CLSI: Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Information supplement. Clinical and Laboratory Standard Institute. 2006, 26: 114-116.
Google Scholar
Swenson JMHJ, Peterson L, : Special phenotypic methods for detecting antibacterial resistance. 1999, Washington DC: ASM Press
Google Scholar
Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier J-D, Nucleo E, Spalla M, Li Bergoli M, Rossolini GM: Nosocomial Outbreak Caused by Multidrug-Resistant Pseudomonas aeruginosa Producing IMP-13 Metallo-{beta}-Lactamase. J Clin Microbiol. 2005, 43 (8): 3824-3828. 10.1128/JCM.43.8.3824-3828.2005
Article
PubMed Central
CAS
PubMed
Google Scholar
Neil Woodford MJE, Coelho Juliana, Turton Jane, Elaina Ward M, Brown Susan, Amyes Sebastian, Livermore David: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. International Journal of Antimicrobial Agents. 2006, 27 (4): 351-353. 10.1016/j.ijantimicag.2006.01.004
Article
PubMed
Google Scholar
O-LC García-Garmendia, Garnacho-Montero J, Jiménez-Jiménez Francisco-Javier, Pérez-Paredes Carmen, Barrero-Almodóvar Ana, Gili-Miner Miguel: Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clinical Infectious Diseases. 2001, 33 (936–946):
Turner PJ, : The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997–2000. Clin MicrobiolInfect. 2003, 9: 563-567.
CAS
Google Scholar
Pagani LMR, Nucleo E, D'Andrea MM, Spalla M, Terulla C, Aquilini E, Labonia M, Li Bergoli M, Rossolini GM: Outbreak of multidrug-resistant Acinetobacter baumannii producing the carbapenem hydrolysing beta-lactamase OXA-58 in a general intensive care unit in Southern Italy. 16th European Congress of Clinical Microbiology and Infectious Diseases. 2006, Nice, France: ESCMID
Google Scholar
Longo BAP, Luzzi I, Placanica P, Gallo S, Tarasi A, Di Sora F, Monaco M, Dionisi AM, Volpe I, Montella F, Cassone A, Rezza G: An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings. Journal of Hospital Infection. 2006, 64 (3): 303-305. 10.1016/j.jhin.2006.07.010
Article
CAS
PubMed
Google Scholar
Zarrilli R, Casillo R, Di Popolo A, Tripodi MF, Bagattini M, Cuccurullo S, Crivaro V, Ragone E, Mattei A, Galdieri N: Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clinical Microbiology and Infection. 2007, 13 (5): 481-489. 10.1111/j.1469-0691.2006.01675.x.
Article
CAS
PubMed
Google Scholar
Giordano Alessandra PV, Bertini Alessia, Villa Laura, Dionisi Maria Anna, Venditti Mario, Carfagna Paolo, Luzzi Ida, Mancini Carlo, Carattoli Alessandra: Outbreak of Acinetobacter baumannii Producing the Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Rome, Italy. Microbial Drug Resistance. 2007, 13 (1): 37-43. 10.1089/mdr.2006.9995
Article
CAS
PubMed
Google Scholar
Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Villari P: Molecular Epidemiology of Sequential Outbreaks of Acinetobacter baumannii in an Intensive Care Unit Shows the Emergence of Carbapenem Resistance. J Clin Microbiol. 2004, 42 (3): 946-953. 10.1128/JCM.42.3.946-953.2004
Article
PubMed Central
CAS
PubMed
Google Scholar
Bertini A, Giordano A, Varesi P, Villa L, Mancini C, Carattoli A: First Report of the Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Acinetobacter baumannii Isolates in Italy. Antimicrob Agents Chemother. 2006, 50 (6): 2268-2269. 10.1128/AAC.00166-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Livermore DM: Tigecycline: what is it, and where should it be used?. J Antimicrob Chemother. 2005, 56 (4): 611-614. 10.1093/jac/dki291
Article
CAS
PubMed
Google Scholar
Betriu C, Rodriguez-Avial I, Sanchez BA, Gomez M, Alvarez J, Picazo JJ: In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain. Antimicrob Agents Chemother. 2002, 46 (3): 892-895. 10.1128/AAC.46.3.892-895.2002
Article
PubMed Central
CAS
PubMed
Google Scholar
Pankey GA: Tigecycline. J Antimicrob Chemother. 2005, 56 (3): 470-480. 10.1093/jac/dki248
Article
CAS
PubMed
Google Scholar
Milatovic D, Schmitz FJ, Verhoef J, Fluit AC: Activities of the Glycylcycline Tigecycline (GAR-936) against 1, 924 Recent European Clinical Bacterial Isolates. Antimicrob Agents Chemother. 2003, 47 (1): 400-404. 10.1128/AAC.47.1.400-404.2003
Article
PubMed Central
CAS
PubMed
Google Scholar
Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N: Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother. 2002, 49 (3): 479-487. 10.1093/jac/49.3.479
Article
CAS
PubMed
Google Scholar
Heritier C, Poirel L, Lambert T, Nordmann P: Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005, 49 (8): 3198-3202. 10.1128/AAC.49.8.3198-3202.2005
Article
PubMed Central
CAS
PubMed
Google Scholar
Livermore D: The impact of Curr Opin Investig Drugs. 2002, 3: 218-224.
Google Scholar
Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, Livermore DM: IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001, 45 (3): 710-714. 10.1128/AAC.45.3.710-714.2001
Article
PubMed Central
CAS
PubMed
Google Scholar
Tognim MC, Gales AC, Penteado AP, Silbert S, Sader HS: Dissemination of IMP-1 metallo-beta-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol. 2006, 27 (7): 742-747. 10.1086/504356
Article
PubMed
Google Scholar
Walsh TR, Toleman MA, Poirel L, Nordmann P: Metallo-beta-lactamases: the quiet before the storm?. Clinical microbiology reviews. 2005, 18 (2): 306-325. 10.1128/CMR.18.2.306-325.2005
Article
PubMed Central
CAS
PubMed
Google Scholar
Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y: Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. Journal of clinical microbiology. 2004, 42 (11): 5256-5263. 10.1128/JCM.42.11.5256-5263.2004
Article
PubMed Central
CAS
PubMed
Google Scholar
Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM: Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999, 43 (7): 1584-1590.
PubMed Central
CAS
PubMed
Google Scholar
Yum JH, Yi K, Lee H, Yong D, Lee K, Kim JM, Rossolini GM, Chong Y: Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes. The Journal of antimicrobial chemotherapy. 2002, 49 (5): 837-840. 10.1093/jac/dkf043
Article
CAS
PubMed
Google Scholar
Wroblewska MM, Towner KJ, Marchel H, Luczak M: Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect. 2007, 13 (5): 490-496. 10.1111/j.1469-0691.2007.01694.x
Article
CAS
PubMed
Google Scholar
Queenan AM, Bush K: Carbapenemases: the versatile beta-lactamases. Clinical microbiology reviews. 2007, 20 (3): 440-458. table of contents 10.1128/CMR.00001-07
Article
PubMed Central
CAS
PubMed
Google Scholar
Walther-Rasmussen J, Hoiby N: Class A carbapenemases. The Journal of antimicrobial chemotherapy. 2007, 60 (3): 470-482. 10.1093/jac/dkm226
Article
CAS
PubMed
Google Scholar
Afzal-Shah M, Livermore DM: Worldwide emergence of carbapenem-resistant Acinetobacter spp. The Journal of antimicrobial chemotherapy. 1998, 41 (5): 576-577. 10.1093/jac/41.5.576
Article
CAS
PubMed
Google Scholar
Marque S, Poirel L, Heritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P: Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. Journal of clinical microbiology. 2005, 43 (9): 4885-4888. 10.1128/JCM.43.9.4885-4888.2005
Article
PubMed Central
CAS
PubMed
Google Scholar
Poirel L, Nordmann P: Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006, 12 (9): 826-836. 10.1111/j.1469-0691.2006.01456.x
Article
CAS
PubMed
Google Scholar
Tsakris A, Ikonomidis A, Spanakis N, Pournaras S, Bethimouti K: Identification of a novel bla(OXA-51) variant, bla(OXA-92), from a clinical isolate of Acinetobacter baumannii. Clin Microbiol Infect. 2007, 13 (3): 348-349. 10.1111/j.1469-0691.2006.01598.x
Article
CAS
PubMed
Google Scholar
Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J: Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. Journal of clinical microbiology. 2007, 45 (2): 453-460. 10.1128/JCM.01971-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhou H, Pi BR, Yang Q, Yu YS, Chen YG, Li LJ, Zheng SS: Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. Journal of medical microbiology. 2007, 56 (Pt 8): 1076-1080. 10.1099/jmm.0.47206-0
Article
CAS
PubMed
Google Scholar
Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J: High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect. 2007, 13 (12): 1192-1198. 10.1111/j.1469-0691.2007.01825.x
Article
CAS
PubMed
Google Scholar
Navon-Venezia S, Leavitt A, Carmeli Y: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii – authors' response. J Antimicrob Chemother. 2007, 60 (1): 178-179. 10.1093/jac/dkm188.
Article
CAS
Google Scholar
Reid Gail ESAG, Aldeza Christine, Janda William, Clark Nina: Rapid Development of Acinetobacter baumannii Resistance to Tigecycline. Pharmacotherapy. 2007, 27 (8): 1198-1201. 10.1592/phco.27.8.1198
Article
CAS
PubMed
Google Scholar
Peleg AY, Adams J, Paterson DL: Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007, 51 (6): 2065-2069. 10.1128/AAC.01198-06
Article
PubMed Central
CAS
PubMed
Google Scholar
Ruzin A, Keeney D, Bradford PA: AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother. 2007, 59 (5): 1001-1004. 10.1093/jac/dkm058
Article
CAS
PubMed
Google Scholar
Curcio D, Fernandez F: Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective. J Antimicrob Chemother. 2007, 60 (2): 449-450. 10.1093/jac/dkm202
Article
CAS
PubMed
Google Scholar
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006, 6 (9): 589-601. 10.1016/S1473-3099(06)70580-1
Article
CAS
PubMed
Google Scholar